John Tavis, PhD

John Tavis, PhD

Primary Academic Title

Professor, Department of Molecular Microbiology and Immunology, St. Louis University School of Medicine

Research Interest

I study hepatitis B virus replication and hepatitis C virus genetics. HBV and HCV together cause 75% of primary liver cancer world-wide. My work with HBV ranges from basic biology to drug discovery. We are currently developing novel anti-HBV ribonuclease H inhibitors as early drug candidates. Our work with HCV extends from basic genetics to development of algorithms predictive of response to therapy.


  • 1990: PhD, molecular and cell biology, Pennsylvania State University, State College, Penn.


  • 1990 - 1991: Post-doctoral scholar, Pennsylvania State University
  • 1991 - 1994: Post-doctoral scholar, University of California, San Francisco

Selected Research Publications

Effects of Troponoids on Mitochondrial Function and Cytotoxicity.
  • Bradley DP, O'Dea AT, Woodson ME, [...] Tavis JE
  • Antimicrob Agents Chemother 2022